| abstract |
The present invention relates to a compound of the general formula (1): wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; R1 is an optionally substituted alkyl group, and the like; and R2 is an optionally substituted amino group, and the like; or a pharmacologically acceptable derivative thereof that possesses an inhibitory activity against cholesteryl cster transfer protein (CETP) |